Aminex Therapeutics Launches Phase 1b/2 Clinical Trial for Innovative Cancer Drug AMXT 1501 Aminex Therapeutics has initiated a Phase 1b/2 clinical trial for their novel cancer treatment, AMXT 1501, demonstrating promise in battling breast cancer and melanoma.

Aminex Therapeutics Launches Phase 1b/2 Clinical Trial for Innovative Cancer Drug AMXT 1501 #None #DFMO #Aminex_Therapeutics #AMXT_1501